title: Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
authors.forename: Carlos
authors.initials: C
authors.lastname: Abud-Mendoza
authors.forename: Marco Ulises
authors.initials: MU
authors.lastname: Martínez-Martínez
authors.forename: José
authors.initials: J
authors.lastname: DE Jesús Macías-Mendoza
authors.forename: Martín
authors.initials: M
authors.lastname: Magaña-Aquino
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003906:Developing Countries; D005260:Female; D006801:Humans; D007194:India; D055985:Latent Tuberculosis / Q000139:chemically induced / Q000175:diagnosis* / Q000517:prevention & control*; D008297:Male; D008800:Mexico; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D014374:Tuberculin Test; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D014409:Tumor Necrosis Factor-alpha